HOME >> MEDICINE >> NEWS
Breakthrough New Therapy Uses Antibody-Targeted Chemotherapy To Fight Leukemia

Scientists presented promising data today at the 35th Annual Meeting of the American Society of Clinical Oncology (ASCO) on the use of a pioneering drug technology known as "antibody-targeted chemotherapy" to fight acute myelogenous leukemia (AML) - a virulent and often fatal form of cancer. The experimental agent, CMA-676, induces remission in a significant proportion of patients with few serious side effects. CMA-676 represents the first successful application of antibody-targeted chemotherapy.

AML is an aggressive, life-threatening disease in which certain white blood cells become cancerous and rapidly replace normal bone marrow and blood cells. AML is among the most serious forms of adult leukemia, with a relatively high fatality rate. Most patients require intensive chemotherapy to achieve complete remission, and some also must undergo bone marrow transplants. Up to half of patients with AML, even after such intensive treatment, have residual leukemic cells or experience a relapse.

Because current chemotherapy drugs to treat AML are non-specific - destroying good as well as bad cells - patients receiving standard chemotherapy tend to become very sick. Researchers at the Fred Hutchinson Cancer Research Center, in collaboration with scientists from thirteen leading leukemia centers, including University of Chicago Medical Center, MD Anderson Cancer Center, and the University of Pennsylvania Cancer Center, are working with Wyeth-Ayerst Research and Celltech PLC to study CMA-676, an antibody-drug conjugate that delivers treatment directly to the leukemia cells.

The specificity of the conjugate lies in the antibody, which recognizes a cell-surface molecule that is abundant on AML cells. Importantly, however, the cell surface molecule is absent from normal blood stem cells, the seeds from which normal blood and immune cells originate. Specially engineered to carry a novel and extremely potent chemotherapy agent known as calicheamic
'"/>

Contact: Susan Edmonds
sedmonds@fhcrc.org
206-667-2896
Fred Hutchinson Cancer Research Center
16-May-1999


Page: 1 2

Related medicine news :

1. Breakthrough in medical research: New chemotherapy gives hope to brain tumour patients
2. Breakthrough therapies treat Crohns disease
3. Breakthrough cancer treatment Avastin receives first approval in the US
4. Breakthroughs in research may bring hope to 1.5 million Americans suffering from peanut allergy
5. Breakthrough in hormonal breast cancer therapy
6. Breakthrough! UNC scientists research promises improved X-ray machines using carbon nanotubes
7. Breakthrough pain in cancer associated with need for increased medical services, higher medical costs
8. Simple test predicts ability to grow new blood vessels: Breakthrough in battle against heart disease, diabetes, cancer
9. Low-Tech Treatment Proves A Life-Saver In Research Breakthrough
10. Breakthrough? Study Finds Dopamine Cannot Be Source Of Pleasure In Brain
11. Hunter College Biologist Marie Filbin Identifies Mechanism That Blocks All Inhibitors Of Nerve Regeneration; Breakthrough Reported In Neuron Magazine

Post Your Comments:
(Date:5/23/2013)... 23, 2013 Great defined abs are the ... everyone strives to achieve in the gym yet so many ... not make this goal become a reality. Great abdominal muscles ... often time overlooked. Scott Tischler of Tischler Brothers Fitness explains ... achieve the goal of great abs. , 1.    Go to bed ...
(Date:5/23/2013)... CA (PRWEB) May 23, 2013 Footwear etc. ... Dansko Vista Collection of sandals containing cork footbeds. Known ... has had consistently good sales for many years, and with ... spring and summer. , Dansko Shoes and ... the Vista Collection is no exception. Containing leather and patent ...
(Date:5/23/2013)... Shirataki noodles are growing in ... a diet strategy. These noodles are originally from Japan ... When losing weight, diet and exercise are the two ... dieters not only research shirataki noodles but offers tons ... buy them. Shirataki noodles are very healthy ...
(Date:5/23/2013)... GBI Research’s analysis indicates that the global ... small number of players accounting for a major proportion of ... growth rate between 2006 and 2012, possibly due to the ... markets, especially in the US. , GBI Research estimates ... billion in 2012, having grown in size at a CAGR ...
(Date:5/22/2013)... 2013 Catalyst Exhibits, Inc., an award-winning ... feature to its website that allows visitors to ... through an immersive, 360-degree, interactive experience. , The ... ability to virtually experience the exhibit design Catalyst created ... and services. Users have the ability to interact with ...
Breaking Medicine News(10 mins):Health News:Scott Tischler of Tischler Brothers Fitness Unveils the 4 Secrets to Getting Abs this Summer 2Health News:Footwear etc. Announces the New Collection of Dansko Cork Sandals 2Health News:DietNoodleShop.com is Re-launching; Adding More Diet Recipes Along with Information on Shirataki Noodles 2Health News:MarketResearch.com Report – Increased Cost of Albumin was Main Factor for Double-Digit Growth of Global Critical Care Market Between 2006 and 2012 2Health News:Catalyst Exhibits Debuts 360 Degree Virtual Tour of St. Jude Medical Trade Show Booth 2
(Date:5/22/2013)... N.Y. , May 22, 2013  MGT Capital ... Company will present at the Second Annual Marcum LLP ... New York City at the Grand ... and Chief Executive Officer, will update investors and answer ... The Company,s presentation is scheduled to begin at ...
(Date:5/22/2013)... May 22, 2013   Life Line Screening ... announced today the creation of a unique partnership with ... MCM is a population health management organization. ... list of clients. These important expanded services will help ... earlier. Effective prevention reduces cost of care when individuals ...
(Date:5/22/2013)... CAMBRIDGE, Mass. , May 22, 2013 /PRNewswire/ ... creation firm focused on healthcare and sustainability, today ... as a Senior Partner. In this ... support to portfolio companies. In addition ... portfolio, Mr. Bancel also serves as President and ...
Breaking Medicine Technology:MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 3MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 4Life Line Screening and MCM Solutions for Better Health Announce New Partnership 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 3
Cached News: